Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 8 Breast Neoplasms 5 Neoplasms 4 Head and Neck Neoplasms 3 Central Nervous System Neoplasms 3 Uterine Cervical Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Oligodendroglioma 2 Melanoma 2 Lung Neoplasms 2 Glioma 2 Glioblastoma 2 Ependymoma 2 Carcinoma, Non-Small-Cell Lung 2 Astrocytoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Metastatic Castration-resistant Prostate Cancer 1 Lymphoma 1 Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 16 Temozolomide 13 Vincristine 10 Irinotecan 8 Melphalan 7 Doxorubicin 7 Topotecan 6 Granulocyte Colony-Stimulating Factor 6 Busulfan 6 fludarabine 5 cabozantinib 5 Etoposide 5 Drug Therapy 5 liposomal doxorubicin 4 Sirolimus 4 Ifosfamide 4 Filgrastim 4 regorafenib 3 pegfilgrastim 3 irinotecan sucrosofate 3 fludarabine phosphate 3 Zoledronic Acid 3 Radiotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Gemcitabine 3 Cisplatin 3 Bone Marrow Transplantation 3 Albumin-Bound Paclitaxel 3 pegylated granulocyte colony-stimulating factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sarcoma, Ewing × alovudine × Clear all

NCT04067115 2025-12-17

U01CA236220

Sarcoma Alliance for Research through Collaboration

Phase 1/2 Completed

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡